Search Results 1791-1800 of 14686 for anti-TNF drugs

1. Metolazone (Oral Route) Precautions - Mayo Clinic

   The results of some tests (e.g., tests for parathyroid function) may be affected by this medicine . Do not take other medicines unless they have been discussed ...

2. Tacrolimus (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Neomycin, Polymyxin B, And Dexamethasone (Ophthalmic Route) Proper Use - Mayo Clinic

   To help clear up your infection completely, keep using this medicine for the full treatment time even if you feel better after the first few doses. The ...

4. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

   ... anti-convulsant medications but only non-enzyme inducing anti-epileptic agents (NEIAED) will be allowed; The subject requires concomitant treatment, in ...

5. Overview - Head and Neck Regenerative Medicine Laboratory - Mayo Clinic Research

   The Head and Neck Regenerative Medicine Lab of David G. Lott, M.D., at Mayo Clinic studies stem cell differentiation, larynx and trachea transplant, ...

6. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   Has had any anti-cancer treatment within 14 days; Has had any investigational agent within 30 days before the first dose of study drug; Radiotherapy within 3 ...

7. Tacrine (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Tacrine is used to treat the symptoms of mild to moderate ...

8. Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome - Mayo Clinic

   Response-based treatment may be effective in treating acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome while reducing ...

9. Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment

   The study focused on predicting the response to methotrexate, one of the most common rheumatoid arthritis medications. Applying patient data that included ...

10. Science Saturday: Finding the right drug, dose for cancer therapy through pharmacogenomics - Mayo Clinic News Network

    Now using pharmacogenomics testing, which looks at how a person's genetic traits affect their medication response, and a new gene verifier model, Dr. Diasio and ...